Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 13/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | BCL9 | O00512 | 2/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30828587 | 0.94 | MCHR1 (0.48) | MCHR1CYP19A1HTR2CKDRBCL9 | |
| SCHEMBL30828576 | 0.83 | MCHR1 (0.52) | MCHR1CYP19A1HTR2C | |
| SCHEMBL30828574 | 0.82 | PTPN1 (0.55) | MCHR1CYP19A1 | |
| SCHEMBL30828580 | 0.82 | PTPN1 (0.43) | MCHR1CYP19A1 | |
| SCHEMBL27193269 | 0.81 | MCHR1 (0.47) | MCHR1CYP19A1HTR2CKDRBCL9 | |
| SCHEMBL27193258 | 0.76 | MCHR1 (0.46) | MCHR1CYP19A1HTR2CKDRBCL9 | |
| SCHEMBL30828549 | 0.75 | ALDH1A1 (0.58) | MCHR1CYP19A1HTR2C | |
| SCHEMBL30828560 | 0.72 | MAPK14 (0.45) | MCHR1 | |
| SCHEMBL30828585 | 0.69 | RAB9A (0.54) | MCHR1CYP19A1 | |
| SCHEMBL30828604 | 0.68 | MAPT (0.55) | MCHR1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | SAINT LOUIS UNIVERSITY (US) | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | ABCC1, ARG1, SLC11A2 | MCHR1 3913/4885CYP19A1 3958/4885HTR2C 4758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.